Skip to main content
Erschienen in: World Journal of Surgery 4/2010

01.04.2010

Lymph Node Ratio Versus Number of Affected Lymph Nodes as Predictors of Survival for Resected Pancreatic Adenocarcinoma

verfasst von: Imran Bhatti, Oliver Peacock, Altaf K. Awan, David Semeraro, Michael Larvin, Richard I. Hall

Erschienen in: World Journal of Surgery | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The objective of this study was to compare the prognostic significance of the lymph node ratio (LNR) with the absolute number of affected lymph nodes for resected pancreatic ductal adenocarcinoma.

Methods

Data were collected from 84 patients who had undergone pancreatoduodenectomy for pancreatic ductal adenocarcinoma over a 10-year period. Patients were categorized into four groups according to the absolute LNR (0, 0–0.199, 0.2–0.299, ≥0.3). Kaplan-Meier and Cox proportional hazard models were used to evaluate the prognostic effect.

Results

An LNR of ≥0.2 (median survival 8.1 vs. 35.7 months with LNR < 0.2; p < 0.001) and ≥0.3 (median survival 5.9 vs. 29.6 months with LNR < 0.3; p < 0.001), tumor size (p < 0.017), positive resection margin (p < 0.001), and nodal involvement (p < 0.001) were found to be significant prognostic markers following univariate analysis. Following multivariate analysis, only LNR at both levels [≥0.2 (p = 0.05; HR 1.8) and LNR of ≥0.3 (p = 0.01; HR 2.7)] were independent predictors of a poor outcome. The number of lymph nodes examined had no effect on overall survival in either node-positive patients (p = 0.339) or node-negative patients (p = 0.473).

Conclusions

The LNR represents a stronger independent prognostic indicator than the absolute number of affected lymph nodes in patients with resected pancreatic ductal adenocarcinoma.
Literatur
1.
Zurück zum Zitat James TA, Sheldon DG, Rajput A et al (2004) Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer 101:2722–2726CrossRefPubMed James TA, Sheldon DG, Rajput A et al (2004) Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer 101:2722–2726CrossRefPubMed
2.
Zurück zum Zitat Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410–1427CrossRefPubMed Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410–1427CrossRefPubMed
3.
Zurück zum Zitat Richter A, Niedergethmann M, Sturm JW et al (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27:324–329CrossRefPubMed Richter A, Niedergethmann M, Sturm JW et al (2003) Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27:324–329CrossRefPubMed
4.
Zurück zum Zitat Connor S, Bosonnet L, Ghaneh P et al (2004) Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. Br J Surg 91:1592–1599CrossRefPubMed Connor S, Bosonnet L, Ghaneh P et al (2004) Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. Br J Surg 91:1592–1599CrossRefPubMed
5.
Zurück zum Zitat Sierzega M, Popiela T, Kulig J et al (2006) The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 33:240–245CrossRefPubMed Sierzega M, Popiela T, Kulig J et al (2006) The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Pancreas 33:240–245CrossRefPubMed
6.
Zurück zum Zitat Berger AC, Watson JC, Ross EA et al (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240; discussion 240PubMed Berger AC, Watson JC, Ross EA et al (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240; discussion 240PubMed
7.
Zurück zum Zitat Neoptolemos JP, Stocken DD, Dunn JA et al (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRefPubMed Neoptolemos JP, Stocken DD, Dunn JA et al (2001) Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758–768CrossRefPubMed
8.
Zurück zum Zitat Winter JM, Cameron JL, Campbell KA et al (2006) 1423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199–1210; discussion 1210–1211CrossRefPubMed Winter JM, Cameron JL, Campbell KA et al (2006) 1423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10:1199–1210; discussion 1210–1211CrossRefPubMed
9.
Zurück zum Zitat Bassi C, Stocken DD, Olah A et al (2005) Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg 22:353–363CrossRefPubMed Bassi C, Stocken DD, Olah A et al (2005) Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial. Dig Surg 22:353–363CrossRefPubMed
10.
Zurück zum Zitat Ueda M, Endo I, Nakashima M et al (2009) Prognostic factors after resection of pancreatic cancer. World J Surg 33:104–110CrossRefPubMed Ueda M, Endo I, Nakashima M et al (2009) Prognostic factors after resection of pancreatic cancer. World J Surg 33:104–110CrossRefPubMed
11.
Zurück zum Zitat Kure S, Kaneko T, Takeda S et al (2005) Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. HPB (Oxford) 7:129–134 Kure S, Kaneko T, Takeda S et al (2005) Analysis of long-term survivors after surgical resection for invasive pancreatic cancer. HPB (Oxford) 7:129–134
12.
Zurück zum Zitat Sohn TA, Yeo CJ, Cameron JL et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567–579CrossRefPubMed Sohn TA, Yeo CJ, Cameron JL et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4:567–579CrossRefPubMed
13.
Zurück zum Zitat House MG, Gonen M, Jarnagin WR et al (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549–1555CrossRefPubMed House MG, Gonen M, Jarnagin WR et al (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549–1555CrossRefPubMed
14.
Zurück zum Zitat Pawlik TM, Gleisner AL, Cameron JL et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610–618CrossRefPubMed Pawlik TM, Gleisner AL, Cameron JL et al (2007) Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 141:610–618CrossRefPubMed
15.
Zurück zum Zitat Tamandl D, Kaczirek K, Gruenberger B et al (2009) Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 96:919–925CrossRefPubMed Tamandl D, Kaczirek K, Gruenberger B et al (2009) Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 96:919–925CrossRefPubMed
16.
Zurück zum Zitat Kulig J, Sierzega M, Kolodziejczyk P et al (2009) Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 96:910–918CrossRefPubMed Kulig J, Sierzega M, Kolodziejczyk P et al (2009) Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 96:910–918CrossRefPubMed
17.
Zurück zum Zitat Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337–1344CrossRefPubMed Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337–1344CrossRefPubMed
18.
Zurück zum Zitat Brennan MF, Kattan MW, Klimstra D et al (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293–298CrossRefPubMed Brennan MF, Kattan MW, Klimstra D et al (2004) Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg 240:293–298CrossRefPubMed
19.
Zurück zum Zitat Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMed Lim JE, Chien MW, Earle CC (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74–85CrossRefPubMed
20.
Zurück zum Zitat Breslin TM, Hess KR, Harbison DB et al (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123–132CrossRefPubMed Breslin TM, Hess KR, Harbison DB et al (2001) Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8:123–132CrossRefPubMed
21.
Zurück zum Zitat Bogoevski D, Onken F, Koenig A et al (2008) Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 247:633–641CrossRefPubMed Bogoevski D, Onken F, Koenig A et al (2008) Is it time for a new TNM classification in esophageal carcinoma? Ann Surg 247:633–641CrossRefPubMed
22.
Zurück zum Zitat Sierra A, Regueira FM, Hernandez-Lizoain JL et al (2003) Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10:219–226CrossRefPubMed Sierra A, Regueira FM, Hernandez-Lizoain JL et al (2003) Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10:219–226CrossRefPubMed
23.
Zurück zum Zitat Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg 248:968–978CrossRefPubMed Rosenberg R, Friederichs J, Schuster T et al (2008) Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg 248:968–978CrossRefPubMed
Metadaten
Titel
Lymph Node Ratio Versus Number of Affected Lymph Nodes as Predictors of Survival for Resected Pancreatic Adenocarcinoma
verfasst von
Imran Bhatti
Oliver Peacock
Altaf K. Awan
David Semeraro
Michael Larvin
Richard I. Hall
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 4/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0336-4

Weitere Artikel der Ausgabe 4/2010

World Journal of Surgery 4/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.